Johnson & Johnson CFO Says This Drug Is Outperforming ‘Almost Any Launch’ in Recent Memory

Summary

Johnson & Johnson's CFO highlighted that one of the company's drugs is outperforming expectations compared to recent product launches. No specific drug name or financial metrics were disclosed in the provided article excerpt.